Erratum : Anti-Inflammatory Efficacy of Human-Derived Streptococcus salivarius on Periodontopathogen-Induced Inflammation

참고문헌 (36)

1. Cekici A, "Inflammatory and immune pathways in the pathogenesis of periodontal disease", Periodontol 2000, 64, pp.57~80 (2014)
2. Socransky SS, "Microbial complexes in subgingival plaque", J. Clin. Periodontol, 25, pp.134~144 (1998)
3. Aruni AW, "Filifactor alocis--a new emerging periodontal pathogen", Microbes Infect, 17, pp.517~530 (2015)
4. Montagner F, "Clustering behavior in microbial communities from acute endodontic infections", J. Endod, 38, pp.158~162 (2012)
5. Yoo HJ, "Virulence of Filifactor alocis lipoteichoic acid on human gingival fibroblast", Arch. Oral Biol, 135, pp.105370~ (2022)
6. Hee-Kyung Park, "Molecular Analysis of Colonized Bacteria in a Human Newborn Infant Gut", The Journal of Microbiology, 43(4), pp.345~353 (2005), 한국미생물학회
7. Carlsson J, "Early establishment of Streptococcus salivarius in the mouth of infants", J. Dent. Res, 49, pp.415~418 (1970)
8. Bourdichon F, "Bulletin of the IDF No 495", 2018; Inventory of Microbial Food Cultures with Safety Demonstration in Fermented Food Products: Update of the Bulletin of the IDF No. 455, 2012, 2018
9. Wescombe PA, "Developing oral probiotics from Streptococcus salivarius", Future Microbiol, 7, pp.1355~1371 (2012)
10. Masdea L, "Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour", Arch. Oral Biol, 57, pp.1041~1047 (2012)
11. Staskova A, "Antimicrobial and antibiofilm activity of the probiotic strain Streptococcus salivarius K12 against oral potential pathogens", Antibiotics (Basel), 10 (2021)
12. Jansen PM, "A concerted probiotic activity to inhibit periodontitis-associated bacteria", PLoS One, 16, pp.e0248308~ (2021)
13. Yoo HJ, "Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro", Clin. Exp. Dent. Res, 6, pp.207~214 (2020)
14. Fields FR, "Complete genome sequence of Streptococcus salivarius DB-B5, a novel probiotic candidate isolated from the supragingival plaque of a healthy female subject", Microbiol. Resour. Announc, 9, pp.e00916-20~ (2020)
15. Poorni S, "Effect of probiotic Streptococcus salivarius K12 and M18lozenges on the cariogram parameters of patients with high caries risk: a randomised control trial", Cureus, 14, pp.e23282~ (2022)
16. Srikham K, "Characterization of Streptococcus salivarius as new probiotics derived from human breast milk and their potential on proliferative inhibition of liver and breast cancer cells and antioxidant activity", Front. Microbiol, 12, pp.797445~ (2021)
17. 김영재, "Reducing the Bioactivity of Tannerella forsythia Lipopolysaccharide by Porphyromonas gingivalis", The Journal of Microbiology, 52(8), pp.702~708 (2014), 한국미생물학회[DOI]
18. Tiong HK, "Comparison of five methods for direct extraction of surface proteins from Listeria monocytogenes for proteomic analysis by orbitrap mass spectrometry", J. Microbiol. Methods, 110, pp.54~60 (2015)
19. Romani Vestman N, "Oral microbiota shift after 12-week supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; a randomized control trial", PLoS One, 10, pp.e0125812~ (2015)
20. Anusha RL, "The magic of magic bugs in oral cavity: probiotics", J. Adv. Pharm. Technol. Res, 6, pp.43~47 (2015)
21. Bowen DM, "Probiotics and oral health", J. Dent. Hyg, 87, pp.5~9 (2013)
22. Patnaik R, "Genome shuffling of Lactobacillus for improved acid tolerance", Nat. Biotechnol, 20, pp.707~712 (2002)
23. Wang RM, "Enhancing acid tolerance of the probiotic bacterium Lactobacillus acidophilus NCFM with trehalose", FEMS Microbiol Lett (2018)[DOI]
24. Akira S, "Toll-like receptor signalling", Nat. Rev. Immunol, 4, pp.499~511 (2004)
25. Al-Qutub MN, "Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide", Infect. Immun, 74, pp.4474~4485 (2006)
26. Henneke P, "Role of lipoteichoic acid in the phagocyte response to group B streptococcus", J. Immunol, 174, pp.6449~6455 (2005)
27. Asai Y, "Treponemal glycoconjugate inhibits Toll-like receptor ligand-induced cell activation by blocking LPS-binding protein and CD14 functions", Eur. J. Immunol, 33, pp.3196~3204 (2003)
28. Lee SH, "Phenol", water extract of Treponema socranskii subsp. socranskii as an antagonist of Toll-like receptor 4 signalling, 2006, pp.152, 535~546
29. Yoshimura A, "Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human Toll-like receptor 4", Infect. Immun, 70, pp.218~225 (2002)
30. Wicken AJ, "Critical micelle concentrations of lipoteichoic acids", J. Bacteriol, 166, pp.72~77 (1986)
31. Schroder NW, "Non-LPS targets and actions of LPS binding protein (LBP)", J. Endotoxin. Res, 11, pp.237~242 (2005)
32. Sugawara S, "Lipoteichoic acid acts as an antagonist and an agonist of lipopolysaccharide on human gingival fibroblasts and monocytes in a CD14-dependent manner", Infect. Immun, 67, pp.1623~1632 (1999)
33. Fischer W, "Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus", Med. Microbiol. Immunol, 183, pp.61~76 (1994)
34. Han SH, "Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2", Infect. Immun, 71, pp.5541~5548 (2003)
35. Jimenez-Dalmaroni MJ, "Soluble human TLR2ectodomain binds diacylglycerol from microbial lipopeptides and glycolipids", Innate Immun, 21, pp.175~193 (2015)
36. Hermann C, "Cytokine induction by purified lipoteichoic acids from various bacterial species--role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release", Eur. J. Immunol, 32, pp.541~551 (2002)

관련 논문AI추천